This proof-of-concept study shows engineered flap creation in NAC scaffolds, suggesting advances in tissue engineering.
Acellular scaffold revascularization is the most significant challenge in tissue and organ engineering. To achieve successful and durable cell growth within complex three-dimensional scaffolds, a functional vascular network must ensure the supply of oxygen and nutrients within the matrix structure. Several teams have studied in vitro and ex vivo re-endothelialization using dynamic cell seeding and bioreactors, among other techniques. Still, to date, no approach has demonstrated long-term successful and functional vascular tree growth within 3D scaffolds. Herein, we propose a promising alternative using the in vivo implantation of decellularized nipple-areolar complex (NAC) scaffolds on a prepared vascular pedicle, thereby achieving engineered flap creation. We compared two implanted groups, one with and one without vascular micropunctures. After 3 weeks, explanted scaffolds demonstrated successful in-depth capillary growth, supported by contrast angiography, histology (including CD31 staining), and macroscopic bleeding. Flow cytometry assays identified different cell contingents, including CD45 and CD31-positive. No significant difference was found between the two implanted groups. This proof-of-concept study offers valuable insights into the successful engineering of composite tissues and organs.
No takes yet. Share an insight, caveat, or question.
Berkane et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: